Page last updated: 2024-11-06

cryptand 2.2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cryptand 2.2: a macrocyclic diaza-crown ether; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72805
CHEMBL ID1812808
SCHEMBL ID59830
MeSH IDM0237221

Synonyms (58)

Synonym
OPREA1_060500
4,7,13,16-tetraoxa-1,10-diazacyclo octadecane
1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
23978-55-4
nsc339325
kryptofix 2.2
diaza-18-crown-6
1,10,16-tetraoxa-4,13-diazacyclooctadecane
nsc-339325
kryptofix 22
1,10,13-tetraoxa-7,16-diazacyclooctadecane
7,16-diaza-18-crown-6
cryptand 22
cryptand 2.2
einecs 245-965-0
nsc 339325
1,7,10,16-tetraoxa-4,13-diazacyclooctadecane
1,10-diaza-4,7,13,16-tetraoxacyclooctadecane
7,16-diaza-1,4,10,13-tetraoxcyclooctadecane
STK367241
1,4,10,13-tetraoxa-7,16-diazacyclooctadecane, >=96%
D2323
4,13-diaza-18-crown 6-ether
AKOS001036576
CHEMBL1812808
BBL010296
xly51t1rsz ,
unii-xly51t1rsz
FT-0616957
29296-32-0
SCHEMBL59830
4,7,13,16-tetraoxa-1,10-diazacyclooctadecane
kryptofix[2.2]
1,10-diaza-18-crown-6
c12h26n2o4
DTXSID20178699
Z56765923
SR-01000596907-1
sr-01000596907
mfcd00005112
H11456
cryptand
J-015299
diaza crown ether 22
kryptand(2.2)
crytand(2,2)
cryptand(2.2)
1,10-diaza-18-crown ether
kryptofix(2.2)
2,2'-kryptofix
1,10-diaza-4,7,13,16-tetraoxa-18-crown-6
7,16-diaza-1,4,10,13-tetraoxacyclooctadecane
4,13-diaza-18-crown-6
SY050937
FS-5990
benzene, 1-(chloromethyl)-4-ethenyl-, homopolymer
CS-W012476
4,13-diaza-18-crown-6-ether
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID611970Antiproliferative activity against human MOLT4 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611969Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611964Antiproliferative activity against human H460 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611986Antibacterial activity against Bacillus subtilis after 70 mins2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611966Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611968Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611967Antiproliferative activity against human MIAPaCa2 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
AID611965Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.44)18.2507
2000's16 (39.02)29.6817
2010's20 (48.78)24.3611
2020's4 (9.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.72 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index5.92 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (97.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]